Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Diagnostics (Basel, Switzerland)|January 23, 2020
Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial HypertensionVasiliki Kalliopi Bournia, Iraklis Tsangaris, Loukianos Rallidis, et al.
Rheumatology International|November 5, 2021
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional studyGeorge E Fragoulis, Vassiliki-Kalliopi Bournia, Eugenia Mavrea, et al.
RMD Open|January 17, 2024
Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort studyMaria P Yavropoulou, Maria G Filippa, Nikolaos I Vlachogiannis, et al.
Rheumatology (Oxford, England)|February 10, 2025
Corticosteroid use in PFAPA syndrome: clinical practice data from the JIR-CliPS Survey Study and a comprehensive literature reviewEzgi Deniz Batu, Seher Sener, Mariana Rodrigues, et al.
Clinical and Experimental Rheumatology|May 15, 2025
On demand corticosteroid use in the syndrome of undifferentiated recurrent fever: a literature review and results from JIR-CLiPS survey studyEzgi Deniz Batu, Seher Sener, Mariana Rodrigues, et al.
Rheumatology International|March 29, 2024
Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseasesAlexandros Panagiotopoulos, George E Fragoulis, Aikaterini Arida, et al.
International Journal of Molecular Sciences|April 28, 2023
Chronological Age and DNA Damage Accumulation in Blood Mononuclear Cells: A Linear Association in Healthy Humans after 50 Years of AgeNikolaos I Vlachogiannis, Panagiotis A Ntouros, Maria Pappa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
A multifaceted interplay between hemophagocytosis, IL-18 and type I IFN distinguishes Still disease from other autoinflammatory diseasesYvonne M Mueller, Charlotte Girard, Harmen J G van de Werken, et al.
Frontiers in Medicine|January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registryAntonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Distinct natural killer cell signature in still's disease: Insights from a multinational immunome project consortium for autoinflammatory disordersAmber De Visscher, Jarne Beliën, Bert Malengier-Devlies, et al.
Pageof 5